1型糖尿病临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 1型糖尿病（国际通用名 type 1 diabetes）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖一型糖尿病等说法。
正在招募的1型糖尿病新药试验
Anhydroglucitol in Children With Type 1 Diabetes
不适用招募中SwitzerlandNCT05594706Montreal Immune-Related Adverse Events (MIRAE) Study
不适用招募中加拿大NCT05139706A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
I 期 / II 期招募中美国NCT07061574Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
不适用招募中美国NCT06880835Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
II 期招募中美国NCT07186660Feasibility Study to Evaluate an Intravascular Blood Continuous Glucose Sensor
不适用招募中BrazilNCT06764069Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial
II 期招募中美国NCT06981234Fasted Exercise Training in Type 1 Diabetes (FED-T1D)
不适用招募中加拿大NCT06748963Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
II 期招募中美国NCT05478707Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
不适用招募中美国NCT05540704GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes
III 期招募中SwitzerlandNCT06630585Screening Program for Type 1 Diabetes in a High-Risk Population
不适用招募中Saudi ArabiaNCT06513247
1型糖尿病试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。
查看四条路径与写信模板